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Several oncological and hematological malignancies may
present with bone disease. Clinical manifestations of
bone disease are mainly osteolytic and /or osteoblastic
skeletal lesions. Preclinical models both in vivo and in
vitro have been developed to study tumor cell biology
within bone microenvironment and have allowed inves-
tigators to better understand pathogenesis of neoplastic
bone disease. These studies represented the basis to
design targeted drugs that were able to restore normal
bone microenvironment and turnover. Among these
drugs, bisphosphonates (BPs) are the current mainstay
of bone disease treatment. Indeed, BPs have been shown
to be very efficient drugs, and are able to revert neoplas-
tic bone turnover. However, BPs may have important
toxicity and among the main side effects, we recognize
osteonecrosis of the jaw. Because of these sequelae,
international oncology societies and networks have sug-
gested clinical guidelines to allow clinical oncologists to
use these drugs in order to obtain the best results with
least toxicities. Furthermore, prevention and treatment
strategies of BP side effects can be best achieved
through close interaction with other related clinical
practitioners such as the dentist and maxillofacial
surgeon.
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